On December 22, Guilin Sanjin Pharmaceutical Co.Ltd(002275) announced that Zou Jieming, the actual controller and chairman (and legal representative) of the company, died of illness on December 21, 2021 at the age of 80.
The announcement said that Zou Jieming, as the main founder of the company, worked hard for the establishment, growth and development of the company, devoted his whole life and made indelible contributions to the development of the company.
according to the announcement, Zou Jieming directly holds 9.05% equity of Guilin Sanjin Pharmaceutical Co.Ltd(002275) and directly or indirectly holds 41.8% equity of the company through himself and his relatives. He is the actual controller of the company.
As of the closing on December 22, Guilin Sanjin Pharmaceutical Co.Ltd(002275) rose 5.17% to 16.88 yuan / share, with a total market value of 9.963 billion yuan, based on this calculation, the market value of Zou Jieming and his relatives’ shares was about 4.165 billion yuan .
Guilin Sanjin Pharmaceutical Co.Ltd(002275) said that after Zou Jieming’s death, the number of current directors of the company was reduced from 9 to 8, which was not lower than the minimum number of directors specified in the company law. The company will make relevant personnel arrangements as soon as possible in accordance with relevant laws and regulations and the articles of association.
The official website of Guilin Sanjin Pharmaceutical Co.Ltd(002275) has changed to black and white
It is understood that Zou Jieming’s two sons Zou Xun and Zou Zhun have entered the senior management of the company. According to the 2020 annual report, his eldest son Zou Xun was born in 1976 and graduated from Nanjing University of technology with a bachelor’s degree. He worked in Guilin Sanjin Pharmaceutical Co.Ltd(002275) finance for two years from 1999 to 2001. Later, he studied at the University of New England and Griffith University in Australia and obtained a master’s degree in international business and accounting and finance. He joined Guilin Sanjin Pharmaceutical Co.Ltd(002275) in October 2007 and is now the vice chairman, executive vice president Secretary of the board of directors.
Zou Zhun was born in August 1980. He graduated from Wuhan University with a bachelor’s degree. Later, he studied at the University of Queensland, Australia, and obtained a master’s degree and an MBA degree in biotechnology. He joined Guilin Sanjin Pharmaceutical Co.Ltd(002275) in April 2010 and is now a director and vice president of the company.
the “watermelon frost king”
Guilin Sanjin Pharmaceutical Co.Ltd(002275) was founded in 1967. Its predecessor was Guilin traditional Chinese medicine factory. It is one of the earliest manufacturers of modern traditional Chinese medicine preparations in China. It is also a leading pharmaceutical enterprise in Guangxi. It has Sanjin tablets, Guilin Watermelon cream and other modern traditional Chinese medicine products famous outside China.
In a media interview in 2018, Zou Jieming summed up his 50 years with Sanjin in this sentence: “in fact, I only did one thing, that is to explore the road of innovating modern traditional Chinese medicine with Guilin Sanjin Pharmaceutical Co.Ltd(002275) .”
The new drug “Sanjin tablet” put into production in 1971 is a new traditional Chinese medicine developed by him on the basis of visiting Chinese Medicine Classics and folk prescriptions and inspired by occasional observations.
In early 1970, Zou Jieming, who was on a business trip to Guangzhou, met an old man with several bags of Medicine on his way. The old man said that the effect of this medicine on urinary tract infection was very good, which made Zou Jieming move in his heart. With the consent of the old man, he checked several packages of medicinal materials. Unexpectedly, he found that the three main drugs were the same as a decoction for the treatment of urinary tract infection.
After returning to Guilin, Zou Jieming, who had grasped the signs of research, went to Yaoshan and Wanfu road to collect medicinal materials, burned them with charcoal and boiled them in an iron pot, and developed Sanjin tablets, a good medicine for the treatment of urinary tract infection, in three years. The invention of the drug won the scientific and technological achievement award of the National Science Conference in 1978. Guilin traditional Chinese medicine factory and Zou Jieming gained a reputation in the same industry in China.
Zou Jieming was not complacent about the success of Sanjin tablets. His eyes focused on another ancient medicine – Watermelon cream.
Watermelon cream is a traditional Chinese medicine with a history of more than 200 years for the treatment of oral and throat diseases. Due to the low frost extraction rate and long production cycle of traditional technology, it can not be mass produced. In 1978, Zou Jieming and his assistant began the process transformation of watermelon frost. After 8 years, by 1986, the snow-white watermelon cream was successfully produced under the new technology developed by Zou Jieming’s team.
The processing technology transformation of watermelon frost has been completed, which completely solves the three problems of large pollution, long production cycle and high cost of traditional hair frost. Watermelon frost production began to enter the industrial era. Zou Jieming is also known as the “watermelon frost king”.
The advent of two original products, Sanjin tablet and watermelon cream, has made Guilin traditional Chinese medicine factory usher in Nirvana and rebirth. Under the promotion of Zou Jieming, the Guilin Sanjin Pharmaceutical Co.Ltd(002275) pharmaceutical group company reorganized based on Guilin traditional Chinese medicine factory was established in March 1994. In 2001, Guilin Sanjin Pharmaceutical Co.Ltd(002275) Pharmaceutical Group was changed to Guilin Sanjin Pharmaceutical Co.Ltd(002275) and landed on Shenzhen Stock Exchange on July 10, 2009.
“Innovation is not only the core factor for enterprises to obtain competitive advantage, but also the most important ability factor for enterprise development.” This is Zou Jieming’s summary of his career for more than 40 years. It is precisely because he took the lead in continuous innovation that ” Guilin Sanjin Pharmaceutical Co.Ltd(002275) ” has gradually grown from a small backward traditional Chinese medicine workshop to today’s listed company.
At present, Sanjin has more than 200 registered varieties and 13 drug dosage forms, and 42 exclusive characteristic varieties independently developed by Guilin Watermelon cream, watermelon cream throat moistening tablets, Sanjin tablets, Naomaitai capsules, etc. After years of efforts, Sanjin has formed strong professional and market advantages in throat, oral medicine and urinary system medicine, and its representative products Sanjin watermelon cream series and Sanjin tablets have been in the forefront of similar Chinese patent medicines in China for many years.
According to the data of the third quarter of this year, Guilin Sanjin Pharmaceutical Co.Ltd(002275) achieved a revenue of 1.256 billion yuan, a year-on-year increase of 14.37%, and the net profit attributable to shareholders of listed companies was 293 million yuan, a year-on-year decrease of 3.98%.
(Beijing business daily)
